کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2406756 | 1103094 | 2008 | 14 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus](/preview/png/2406756.png)
SummaryWest Nile virus (WNV) is a mosquito borne, neurotropic flavivirus that causes a severe central nervous system (CNS) infection in humans and animals. Although commercial vaccines are available for horses, none is currently approved for human use. In this study, we evaluated the efficacy and mechanism of immune protection of two candidate WNV vaccines in mice. A formalin-inactivated WNV vaccine induced higher levels of specific and neutralizing antibodies compared to a DNA plasmid vaccine that produces virus-like particles. Accordingly, partial and almost complete protection against a highly stringent lethal intracranial WNV challenge were observed in mice 60 days after single dose immunization with the DNA plasmid and inactivated virus vaccines, respectively. In mice immunized with a single dose of DNA plasmid or inactivated vaccine, antigen-specific CD8+ T cells were induced and contributed to protective immunity as acquired or genetic deficiencies of CD8+ T cells lowered the survival rates. In contrast, in boosted animals, WNV-specific antibody titers were higher, survival rates after challenge were greater, and an absence of CD8+ T cells did not appreciably affect mortality. Overall, our experiments suggest that in mice, both inactivated WNV and DNA plasmid vaccines are protective after two doses, and the specific contribution of antibody and CD8+ T cells to vaccine immunity against WNV is modulated by the prime-boost strategy.
Journal: Vaccine - Volume 26, Issue 16, 7 April 2008, Pages 2020–2033